Condition

Thromboprophylaxis clinical trials and research

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• Can apixaban prevent blood clots in ambulatory lung cancer patients on chemotherapy?

  This trial tests whether taking apixaban can reduce blood clots in people with lung cancer who are receiving chemotherapy, compared with a placebo.

  Recruiting at 8 sites Phase 3 University of Birmingham · Dorchester and 7 other locations · NCT07160686

• Comparing rivaroxaban and low-molecular weight heparin for preventing blood clots in patients with lower limb trauma

  This study is testing if a new blood thinner called rivaroxaban can prevent blood clots better than a standard treatment in patients with leg injuries who are at high risk for clots.

  Recruiting at 26 sites Phase 3 University Hospital, Angers · Agen and 36 other locations · NCT06195540

Related topics

Quick answers

How many Thromboprophylaxis clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in France (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →